ARCHIVES

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

In Brief: Foundation Funds Six Lung Cancer Studies; Schilsky Re-elected CALGB Chairman

November 19, 1999

Upton Leaning to New Division for Centers, Organ Sites, Education

August 25, 1978

In Brief: Oncology Nursing Society Names Board Of Directors

May 16, 2014

Pressure Grows On Upton To Reveal Plans

November 23, 1979